EMMAUS LIFE Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>EMM</div>

Performance

0 / 100

Odds of Distress

Analyze Filter   Earning Report: February 13, 2020
Equity ratings for EMMAUS LIFE SCIENCES INC NEW are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting October 28, 2019 and ending today January 26, 2020. Please note, there could be an existing legal relationship between EMMAUS LIFE SCIENCES (EMMA) and Emmaus Life Sciences (CNSO). Click here to learn more.

EMMAUS LIFE Profile

Upcoming quarterly earning report is expected on February 13, 2020. Emmaus Life Sciences, Inc. engages in the discovery, development, and commercialization of treatments and therapies primarily for rare and orphan diseases in the United States and internationally. Emmaus Life Sciences, Inc. was founded in 2000 and is headquartered in Torrance, California. EMMAUS LIFE operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 28 people. more on EMMAUS LIFE
EMMAUS LIFE Fama & French Healthcare
Healthcare
Fama & French Classification
EMMAUS LIFE SCIENCES SEC Filings
EMMAUS LIFE SEC Filings
Security & Exchange Commission EDGAR ReportsView All
Legal NameEMMAUS LIFE SCIENCES INC NEW
Related EntityCNSO (Emmaus Life Sciences)
ChairmanWillis LeeView All
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Average Analyst Recommendation
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Financial Strength
EMMAUS LIFE SCIENCES ability to generate sufficient cash flow to pay bills, repay debt, and make consistent year-to-year profit
Total Debt
Debt Current
Debt Non Current
Debt to Equity Ratio
Return on Average Assets
Return on Average Equity
Return on Invested Capital
Return on Sales
Earnings per Basic Share
Earnings per Diluted Share
Price to Earnings Ratio
Earnings before Tax
Profitability
Few selected profitability drivers of EMMAUS LIFE representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Consolidated Income
Net Income
Net Income Common Stock
Operating Income
Income Tax Expense
EBITDA Margin
Gross Margin
Profit Margin
EMMAUS LIFE SCIENCES INC NEW [EMMA] is traded as part of a regulated electronic over-the-counter service offered by the NASD. EMMAUS LIFE is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with current market capitalization of 87.12 M. EMMAUS LIFE SCIENCES conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 48.47 M outstanding shares of which 41.22 K shares are currently shorted by private and institutional investors with about 0.48 trading days to cover. The company currently holds about 41.19 M in cash with (5.99 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85.
Check EMMAUS LIFE Probability Of Bankruptcy

Ownership Allocation (%)

EMMAUS LIFE Target Price Odds Analysis

Odds Below 1.42HorizonTargetOdds Above 1.42
4.33%30 days 1.42 95.65%
Based on normal probability distribution, the odds of EMMAUS LIFE to move above current price in 30 days from now is over 95.65 (This EMMAUS LIFE SCIENCES INC NEW probability density function shows the probability of EMMAUS LIFE OTC Stock to fall within a particular range of prices over 30 days) .

EMMAUS LIFE SCIENCES Top Holders

EMMAUS LIFE SCIENCES INC NEW Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

EMMAUS LIFE Against Markets

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

EMMAUS LIFE Upcoming and Recent Events

EMMAUS LIFE Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 13, 2020
Next Earnings ReportMay 8, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 13, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

EMMAUS LIFE Corporate Filings

EMMAUS LIFE SEC Reporting

Financial Statements and Exhibits. Changes in Registrant's Certifying Accountant
Entry into a Material Definitive Agreement
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year

EMMAUS LIFE Corporate Directors

Wei Zen Director
Robert Dickey Director
Ian Zwicker Director
Continue to Investing Opportunities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Company logos by clearbit